Synergy of a novel antibiotic adjuvant entity against multi drug resistant Methicillin-resistant Staphylococcus aureus and heterogeneous glycopeptide-intermediate Staphylococcus aureus

This study suggests that vancomycin with l-arginine and ceftriaxone could be an alternative regimen in combating antibiotic resistance among MRSA and hGISA.